Schalin-Jäntti C - Search Results

1

Skeletal Characteristics of WNT1 Osteoporosis in Children and Young Adults.

Mäkitie RE, Haanpää M, Valta H, Pekkinen M, Laine CM, Lehesjoki AE, Schalin-Jäntti C, Mäkitie O. Mäkitie RE, et al. J Bone Miner Res. 2016 Sep;31(9):1734-42. doi: 10.1002/jbmr.2841. Epub 2016 Apr 25. J Bone Miner Res. 2016. PMID: 27005318 Free article.

2

Impaired WNT signaling and the spine-Heterozygous WNT1 mutation causes severe age-related spinal pathology.

Mäkitie RE, Niinimäki T, Nieminen MT, Schalin-Jäntti C, Niinimäki J, Mäkitie O. Mäkitie RE, et al. Bone. 2017 Aug;101:3-9. doi: 10.1016/j.bone.2017.04.001. Epub 2017 Apr 11. Bone. 2017. PMID: 28411110

3

Cinacalcet Rectifies Hypercalcemia in a Patient With Familial Hypocalciuric Hypercalcemia Type 2 (FHH2) Caused by a Germline Loss-of-Function Gα₁₁ Mutation.

Gorvin CM, Hannan FM, Cranston T, Valta H, Makitie O, Schalin-Jantti C, Thakker RV. Gorvin CM, et al. J Bone Miner Res. 2018 Jan;33(1):32-41. doi: 10.1002/jbmr.3241. Epub 2017 Sep 22. J Bone Miner Res. 2018. PMID: 28833550 Free PMC article.

4

An ARHGAP25 variant links aberrant Rac1 function to early-onset skeletal fragility.

Mäkitie RE, Henning P, Jiu Y, Kämpe A, Kogan K, Costantini A, Välimäki VV, Medina-Gomez C, Pekkinen M, Salusky IB, Schalin-Jäntti C, Haanpää MK, Rivadeneira F, Bassett JHD, Williams GR, Lerner UH, Pereira RC, Lappalainen P, Mäkitie O. Mäkitie RE, et al. JBMR Plus. 2021 Jun 7;5(7):e10509. doi: 10.1002/jbm4.10509. eCollection 2021 Jul. JBMR Plus. 2021. PMID: 34258505 Free PMC article.

5

Identification and characterization of melanocortin-4 receptor gene mutations in morbidly obese finnish children and adults.

Valli-Jaakola K, Lipsanen-Nyman M, Oksanen L, Hollenberg AN, Kontula K, Bjørbaek C, Schalin-Jäntti C. Valli-Jaakola K, et al. J Clin Endocrinol Metab. 2004 Feb;89(2):940-5. doi: 10.1210/jc.2003-031182. J Clin Endocrinol Metab. 2004. PMID: 14764818

6

Postoperative zoledronic acid for osteoporosis in primary hyperparathyroidism: a randomized placebo-controlled study.

Ryhänen EM, Koski AM, Löyttyniemi E, Välimäki MJ, Kiviniemi U, Schalin-Jäntti C. Ryhänen EM, et al. Eur J Endocrinol. 2021 Aug 27;185(4):515-524. doi: 10.1530/EJE-21-0322. Eur J Endocrinol. 2021. PMID: 34324430 Clinical Trial.

7

A two-base deletion -439delGC in the melanocortin-4 receptor promoter associated with early-onset obesity.

Valli-Jaakola K, Palvimo JJ, Lipsanen-Nyman M, Salomaa V, Peltonen L, Kontula K, Schalin-Jäntti C. Valli-Jaakola K, et al. Horm Res. 2006;66(2):61-9. doi: 10.1159/000093469. Epub 2006 May 19. Horm Res. 2006. PMID: 16710097

8

Thyroid-stimulating hormone and mortality in older people.

Schalin-Jäntti C, Ojala AK, Pitkälä KH, Tilvis RS, Strandberg TE. Schalin-Jäntti C, et al. J Am Geriatr Soc. 2013 Oct;61(10):1823-4. doi: 10.1111/jgs.12485. J Am Geriatr Soc. 2013. PMID: 24117299 No abstract available.

9

Recurrent Metastasized Parathyroid Carcinoma-Long-Term Remission After Combined Treatments With Surgery, Radiotherapy, Cinacalcet, Zoledronic Acid, and Temozolomide.

Storvall S, Ryhänen E, Bensch FV, Heiskanen I, Kytölä S, Ebeling T, Mäkelä S, Schalin-Jäntti C. Storvall S, et al. JBMR Plus. 2018 Nov 29;3(4):e10114. doi: 10.1002/jbm4.10114. eCollection 2019 Apr. JBMR Plus. 2018. PMID: 31044184 Free PMC article.

10

Physiology of Calcium Homeostasis: An Overview.

Matikainen N, Pekkarinen T, Ryhänen EM, Schalin-Jäntti C. Matikainen N, et al. Endocrinol Metab Clin North Am. 2021 Dec;50(4):575-590. doi: 10.1016/j.ecl.2021.07.005. Endocrinol Metab Clin North Am. 2021. PMID: 34774235 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

112 results

Search Page

Filters